P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses

Documenti analoghi

• IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer
  di: Olena Kourko, et al.
  Pubblicazione: (2019-10-01)
• Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.
  di: Giri, J G, et al.
  Pubblicazione: (1994)
• Assessment of the levels of nitric oxide (NO) and cytokines (IL-5, IL-6, IL-13, TNF, IFN-gamma) in giardiosis
  di: Halina Kemona, et al.
  Pubblicazione: (2011-07-01)
• Trifunctional antibody-cytokine fusion protein formats for tumor-targeted combination of IL-15 with IL-7 or IL-21
  di: Annika M. Möller, et al.
  Pubblicazione: (2025-04-01)
• Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma
  di: Rahim Farahani, et al.
  Pubblicazione: (2014-01-01)